Dow Down 0.62% Nasdaq Down 1.14%

Sunesis Pharmaceuticals, Inc. (SNSS)

-NasdaqCM
7.14 Down 0.20(2.72%) 4:00PM EDT
Prev Close:7.34
Open:7.29
Bid:7.07 x 3000
Ask:N/A
1y Target Est:11.33
Beta:2.8
Next Earnings Date:N/A
Day's Range:6.86 - 7.32
52wk Range:3.84 - 8.46
Volume:1,767,665
Avg Vol (3m):841,591
Market Cap:431.56M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNSSDown 2.72%431.56M
AZNDown 0.07%94.31B
PFEDown 0.72%191.37B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):55.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.74
Quarterly EPS Est (Sep-14) :-0.20
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sunesis Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback